Enterprise software companies are experiencing a transformation as AI integration drives unprecedented demand. Companies like Zoom are already raising their forecasts based on strong AI tool adoption.
AI-enhanced software typically commands premium pricing and delivers better customer value. This could translate into improved subscription revenues and wider profit margins for successful adopters.
Investors are increasingly backing companies that effectively monetise their AI capabilities. This group captures firms positioned to benefit from this wave of recognition and investment.
Recent upward forecast revisions from companies like Zoom signal a new growth phase for enterprise software firms successfully embedding AI into their core products. This trend represents a compelling opportunity as the market begins to reward companies that effectively monetise their AI capabilities, potentially leading to higher subscription revenues and wider profit margins.
These companies operate across the enterprise software landscape, providing everything from customer relationship management and data analytics to collaboration and automation tools. By integrating AI, they aim to deliver more value to customers, which could translate into stronger financial performance and competitive advantages in their respective markets.
This tactical collection was curated to capture companies poised to benefit from the wave of AI adoption in enterprise software. Each firm has been selected based on their ability to successfully integrate AI into their platforms, offering thematic exposure to a key driver of innovation in the technology sector.
Zoom raised its annual financial forecasts, citing strong demand for its new artificial intelligence tools. This highlights a broader investment opportunity in enterprise software companies that are successfully integrating AI to drive growth and enhance their product offerings.
Summary and investor key takeaways for the basket's market capitalisation and concentration.
ZM: $25.02B
CRM: $250.77B
NOW: $195.83B
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
Es dauert nur 60 Sekunden.
+8
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 125.22 % zulegen.
11 von 16 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+125.22%
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Vollständige Analyse lesen
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
